-
-
Call more information
660-596-2224 -
Authors: Dylan Irvine, BScH; Jeffrey Huang, MD Anesthesia Patient Safety Foundation Volume 37, No. 2 June 2022 Introduction The subspeciality of onco-anesthesia has gradually gained traction over the past few years. In addition to the comorbid diseases that some cancer patients present with, the interactions and consequences of their antineoplastic regimens must also be considered […]
Read MoreAuthor: Morgan Meissner PhD MedicalNewsToday Stress, hormonal changes, and certain types of foods can all trigger migraine attacks. Some people with migraine find that environmental conditions, including air quality, also affect their symptoms. For people living with migraine, identifying triggers that cause migraine episodes can be a helpful way to minimize the disruptive nature of […]
Read MoreA case report Authors: Kim, Kanghui MD; Jung, Sung Mee MD, PhD∗ Editor(s): Saranathan., Maya Medicine: March 04, 2022 – Volume 101 – Issue 9 – p e28954 Rationale: Hyperammonemia, metabolic derangement, and/or the prolonged effects of anesthetics may lead to delayed emergence from general anesthesia as well as the onset of type 2 citrullinemia, even […]
Read MoreAuthors: Dylan Irvine, BScH; Tricia Meyer, PharmD, MS; John Williams, MD; Jeffrey Huang, MD Anesthesia Pateitn Safety Foundation Volume 37, No. 2 June 2022 Introduction As of 2018, an estimated 9.5% of the United States adult population were cannabis users.1 This percentage has likely continued to increase with the use of both recreational and medicinal cannabis […]
Read MoreAUTHORS: Dermot P. Maher, M.D., M.S., M.H.S. et al Anesthesiology June 2022. Background The authors estimate the probability of successful development and duration of clinical trials for medications to treat neuropathic and nociceptive pain. The authors also consider the effect of the perceived abuse potential of the medication on these variables. Methods This study uses […]
Read MoreAUTHORS: Friedrichson, Benjamin et al European Journal of Anaesthesiology: May 2022 – Volume 39 – Issue 5 – p 445-451 BACKGROUND In the context of the coronavirus disease 2019 (COVID-19) pandemic, many retrospective single-centre or specialised centre reports have shown promising mortality rates with the use of extracorporeal membrane oxygenation (ECMO) therapy. However, the mortality rate […]
Read MoreAUTHORS: Kristian Kjaer-Staal Petersen et al Eur J Pain. 2022 May 31 BACKGROUND Duloxetine is indicated in the management of pain in osteoarthritis. Evidence suggests that duloxetine modulate central pain mechanisms and cognitive factors, and these factors are assumed contributing to the analgesic effect. This proof-of-mechanism, randomized, placebo-controlled, crossover, double-blinded trial evaluated the effect of […]
Read MoreAuthor: Brian Thomas, JD et al Anesthesia Patient Safety Foundation Volume 37, No. 2 June 2022 Administration of sevoflurane at low-flow rates remains a controversial practice due to the low-flow limits described in the Food and Drug Administration’s (FDA) required labeling. Specifically, the labeling in the United States requires no less than 1 L/min for […]
Read MoreAuthors: Kimberley Lewis et al Intensive Care Med. 2022 Jun 1 Conventional gabaminergic sedatives such as benzodiazepines and propofol are commonly used in mechanically ventilated patients in the intensive care unit (ICU). Dexmedetomidine is an alternative sedative that may achieve lighter sedation, reduce delirium, and provide analgesia. Our objective was to perform a comprehensive systematic […]
Read MoreAuthors: Jeffrey M. Feldman, MD, MSE; Samsun Lampotang, PhD, FSSH, FAIMBE Anesthesia Patient Safety Foundation Volume 37, No. 2 June 2022 The benefits of low-flow anesthesia are well established and include reduced inhaled anesthetic waste, decreased cost, and fewer greenhouse gas effects.1 For the individual patient, low-flow anesthesia reduces loss of heat and humidity from the […]
Read More